UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial

The journals of gerontology. Series A, Biological sciences and medical sciences, 2016-05, Vol.71 (5), p.649-655

2016

Volltextzugriff (PDF)

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial

American journal of hypertension, 2018-01, Vol.31 (1), p.97-107

2018

Volltextzugriff (PDF)

Bekenstein’s Entropy Bound-Particle Horizon Approach to Avoid the Cosmological Singularity

Entropy (Basel, Switzerland), 2020-07, Vol.22 (7), p.795

2020

Volltextzugriff (PDF)

Sodium‐glucose co‐transporter‐2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials

Diabetes, obesity & metabolism, 2021-01, Vol.23 (1), p.276-280

2021

Volltextzugriff (PDF)

Implementing the association between rosacea, hypertension, and dyslipidemia in clinical practice

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.e167-e167

2021

Volltextzugriff (PDF)

A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?

Diabetes/metabolism research and reviews, 2024-01, Vol.40 (1), p.e3715-n/a

2024

Volltextzugriff (PDF)

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme

Cancers, 2024-09, Vol.16 (19), p.3351

2024

Volltextzugriff (PDF)

GLP‐1 RA and atrial fibrillation in the cardiovascular outcome trials

Diabetes/metabolism research and reviews, 2021-07, Vol.37 (5), p.e3436-n/a

2021

Volltextzugriff (PDF)

Diabetes-Related Microvascular Complications – A Practical Approach

Primary care, 2022-06, Vol.49 (2), p.239-254

2022

Volltextzugriff (PDF)

Do GLP‐1RAs and SGLT‐2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis

Diabetes, obesity & metabolism, 2019-10, Vol.21 (10), p.2274-2283

2019

Volltextzugriff (PDF)

102-LB: Cumulative Probability of Mortality among Non-Hispanic Black Compared with Non-Hispanic White Individuals with Type 2 Diabetes on Empagliflozin (EMPA-AA)—Real-World Data

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data

Diabetes, obesity & metabolism, 2024-05, Vol.26 (5), p.1830-1836

2024

Volltextzugriff (PDF)

The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials

Diabetes research and clinical practice, 2021-07, Vol.177, p.108878-108878, Article 108878

2021

Volltextzugriff (PDF)

Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes

Primary care diabetes, 2022-06, Vol.16 (3), p.471-473

2022

Volltextzugriff (PDF)

20-LB: Heart Failure Hospitalization among African American Compared with White Individuals with Type 2 Diabetes on Empagliflozin—Real-World Data

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

2390-PUB: A Diabetes Clinic in the Primary Care Setting: A Quality Improvement Initiative in a Teaching Institution—One-Year Data

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Impact of Intensive Blood Pressure Therapy on Concern about Falling: Longitudinal Results from the Systolic Blood Pressure Intervention Trial (SPRINT)

Journal of the American Geriatrics Society (JAGS), 2020-03, Vol.68 (3), p.614-618

2020

Volltextzugriff (PDF)

Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record

Contemporary clinical trials, 2023-05, Vol.128, p.107172-107172, Article 107172

2023

Volltextzugriff (PDF)

2365-PUB: Can Baseline Hemoglobin A1c Help Guide Treatment with an SGLT2i vs. DPP-4i? A Meta-analysis

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

242-OR: Do GLP-1RA and SGLT2i Reduce Cardiovascular Mortality in African-American Patients with Type 2 Diabetes? A Meta-analysis

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

2363-PUB: The Efficacy of Low vs. High FDA-Approved SGLT2 Inhibitor Dose Compared with DPP-4 Inhibitors: A Meta-analysis

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Low‐salt diet adherence in African Americans with hypertension

Journal of clinical nursing, 2018-10, Vol.27 (19-20), p.3750-3757

2018

Volltextzugriff (PDF)

Should Baseline Hemoglobin A1c or Dose of SGLT‐2i Guide Treatment With SGLT‐2i Versus DPP‐4i in People With Type 2 Diabetes? A Meta‐Analysis and Systematic Review

Journal of clinical pharmacology, 2020-08, Vol.60 (8), p.980-991

2020

Volltextzugriff (PDF)

Should Baseline Hemoglobin A 1c or Dose of SGLT-2i Guide Treatment With SGLT-2i Versus DPP-4i in People With Type 2 Diabetes? A Meta-Analysis and Systematic Review

Journal of clinical pharmacology, 2020-08, Vol.60 (8), p.980-991

2020

Volltextzugriff (PDF)

Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention Trial

Journal of the American Geriatrics Society (JAGS), 2016-11, Vol.64 (11), p.2302-2306

2016

Volltextzugriff (PDF)

1 – 25 von 1.541

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.319)
Mit Volltextzugriff
(1.210)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(32)
Nature
(15)
Pediatrics
(15)
The New England Journal Of Medicine
(15)
Jama : The Journal Of The American Medical Association
(14)
Plos One
(14)
The Lancet
(13)
Proceedings Of The National Academy Of Sciences - Pnas
(12)
Cancer Research
(11)
Gastroenterology
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial

Bekenstein’s Entropy Bound-Particle Horizon Approach to Avoid the Cosmological Singularity

Sodium‐glucose co‐transporter‐2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials

Implementing the association between rosacea, hypertension, and dyslipidemia in clinical practice

A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme

GLP‐1 RA and atrial fibrillation in the cardiovascular outcome trials

Diabetes-Related Microvascular Complications – A Practical Approach

Do GLP‐1RAs and SGLT‐2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis

102-LB: Cumulative Probability of Mortality among Non-Hispanic Black Compared with Non-Hispanic White Individuals with Type 2 Diabetes on Empagliflozin (EMPA-AA)—Real-World Data

Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data

The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials

Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes

20-LB: Heart Failure Hospitalization among African American Compared with White Individuals with Type 2 Diabetes on Empagliflozin—Real-World Data

2390-PUB: A Diabetes Clinic in the Primary Care Setting: A Quality Improvement Initiative in a Teaching Institution—One-Year Data

Impact of Intensive Blood Pressure Therapy on Concern about Falling: Longitudinal Results from the Systolic Blood Pressure Intervention Trial (SPRINT)

Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record

2365-PUB: Can Baseline Hemoglobin A1c Help Guide Treatment with an SGLT2i vs. DPP-4i? A Meta-analysis

242-OR: Do GLP-1RA and SGLT2i Reduce Cardiovascular Mortality in African-American Patients with Type 2 Diabetes? A Meta-analysis

2363-PUB: The Efficacy of Low vs. High FDA-Approved SGLT2 Inhibitor Dose Compared with DPP-4 Inhibitors: A Meta-analysis

Low‐salt diet adherence in African Americans with hypertension

Should Baseline Hemoglobin A1c or Dose of SGLT‐2i Guide Treatment With SGLT‐2i Versus DPP‐4i in People With Type 2 Diabetes? A Meta‐Analysis and Systematic Review

Should Baseline Hemoglobin A 1c or Dose of SGLT-2i Guide Treatment With SGLT-2i Versus DPP-4i in People With Type 2 Diabetes? A Meta-Analysis and Systematic Review

Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention Trial

Suchergebnisse filtern